Moolec Science S.A.
MLEC · NASDAQ
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $1 | $0 | $0 |
| % Growth | 521.5% | – | – | – |
| Cost of Goods Sold | $5 | $1 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 8.4% | -15.8% | – | – |
| R&D Expenses | $2 | $1 | $1 | $0 |
| G&A Expenses | $7 | $47 | $3 | $0 |
| SG&A Expenses | $7 | $48 | $3 | $0 |
| Sales & Mktg Exp. | $1 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | -$43 | $0 | $0 |
| Operating Expenses | $10 | $7 | $4 | $0 |
| Operating Income | -$9 | -$7 | -$2 | -$0 |
| % Margin | -160.8% | -735.2% | – | – |
| Other Income/Exp. Net | $1 | -$45 | $2 | $0 |
| Pre-Tax Income | -$8 | -$52 | -$0 | -$0 |
| Tax Expense | -$1 | -$0 | $0 | $0 |
| Net Income | -$7 | -$52 | -$5 | -$0 |
| % Margin | -130% | -5,722.2% | – | – |
| EPS | -0.19 | -1.5 | -0.12 | -0.001 |
| % Growth | 87.3% | -1,150% | -14,900% | – |
| EPS Diluted | -0.19 | -1.5 | -0.12 | -0.001 |
| Weighted Avg Shares Out | 38 | 34 | 38 | 17 |
| Weighted Avg Shares Out Dil | 38 | 34 | 38 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$6 | -$52 | -$4 | -$0 |
| % Margin | -109.5% | -5,717% | – | – |